Viveve Medical Inc. (VIVMF) Financials Nov 14, 201
Post# of 250675
Posted On: 11/17/2014 2:45:00 AM
Viveve Medical Inc. (VIVMF) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Viveve Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.71M 3.91M 671,000 1.08M 1.27M
Cost of Goods Sold (COGS) incl. D&A 2.1M 1.38M 426,000 541,000 531,000
COGS excluding D&A 2M 1.33M 417,000 498,000 478,000
Depreciation & Amortization Expense 96,000 42,000 9,000 43,000 53,000
Depreciation 91,000 42,000 9,000 43,000 53,000
Amortization of Intangibles 5,000 - 0 0 0
Gross Income 2.61M 2.54M 245,000 539,000 743,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.24M 3.14M 3.66M 4.66M 5.45M
Research & Development 780,000 333,000 1.21M 2.03M 2.12M
Other SG&A 3.46M 2.81M 2.45M 2.63M 3.33M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 2.7M 3.64M (8.5M)
EBIT after Unusual Expense 0 0 (2.7M) (3.64M) 8.5M
Non Operating Income/Expense 3,000 98,000 (490,000) 14,000 36,000
Non-Operating Interest Income - - 10,000 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 396,000 635,000 337,000
Gross Interest Expense 0 0 396,000 635,000 337,000
Interest Capitalized - 0 0 0 0
Pretax Income (1.63M) (505,000) (6.99M) (8.39M) 3.5M
Income Tax 0 0 (492,000) 0 0
Income Tax - Current Domestic 0 0 (492,000) 0 -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.63M) (505,000) (6.5M) (8.39M) 3.5M
Minority Interest Expense 0 0 0 0 0
Net Income (1.63M) (505,000) (6.5M) (8.39M) 3.5M
Extraordinaries & Discontinued Operations 0 0 740,000 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 687,000 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 53,000 0 0
Net Income After Extraordinaries (1.63M) (505,000) (5.76M) (8.39M) 3.5M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.63M) (505,000) (6.5M) (8.39M) 3.5M
EPS (Basic) (5.00) (2.00) (21.00) (27.00) 5.00
Basic Shares Outstanding 303,510 303,510 303,510 311,390 770,610
EPS (Diluted) (5.00) (2.00) (21.00) (27.00) 3.00
Diluted Shares Outstanding 303,510 303,510 303,510 311,390 1.13M
EBITDA (1.53M) (561,000) (3.4M) (4.08M) (4.65M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Viveve Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.71M 3.91M 671,000 1.08M 1.27M
Cost of Goods Sold (COGS) incl. D&A 2.1M 1.38M 426,000 541,000 531,000
COGS excluding D&A 2M 1.33M 417,000 498,000 478,000
Depreciation & Amortization Expense 96,000 42,000 9,000 43,000 53,000
Depreciation 91,000 42,000 9,000 43,000 53,000
Amortization of Intangibles 5,000 - 0 0 0
Gross Income 2.61M 2.54M 245,000 539,000 743,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.24M 3.14M 3.66M 4.66M 5.45M
Research & Development 780,000 333,000 1.21M 2.03M 2.12M
Other SG&A 3.46M 2.81M 2.45M 2.63M 3.33M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 2.7M 3.64M (8.5M)
EBIT after Unusual Expense 0 0 (2.7M) (3.64M) 8.5M
Non Operating Income/Expense 3,000 98,000 (490,000) 14,000 36,000
Non-Operating Interest Income - - 10,000 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 396,000 635,000 337,000
Gross Interest Expense 0 0 396,000 635,000 337,000
Interest Capitalized - 0 0 0 0
Pretax Income (1.63M) (505,000) (6.99M) (8.39M) 3.5M
Income Tax 0 0 (492,000) 0 0
Income Tax - Current Domestic 0 0 (492,000) 0 -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.63M) (505,000) (6.5M) (8.39M) 3.5M
Minority Interest Expense 0 0 0 0 0
Net Income (1.63M) (505,000) (6.5M) (8.39M) 3.5M
Extraordinaries & Discontinued Operations 0 0 740,000 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 687,000 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 53,000 0 0
Net Income After Extraordinaries (1.63M) (505,000) (5.76M) (8.39M) 3.5M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.63M) (505,000) (6.5M) (8.39M) 3.5M
EPS (Basic) (5.00) (2.00) (21.00) (27.00) 5.00
Basic Shares Outstanding 303,510 303,510 303,510 311,390 770,610
EPS (Diluted) (5.00) (2.00) (21.00) (27.00) 3.00
Diluted Shares Outstanding 303,510 303,510 303,510 311,390 1.13M
EBITDA (1.53M) (561,000) (3.4M) (4.08M) (4.65M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)